Secretory changes in preovulatory endometrium during controlled ovarian hyperstimulation with buserelin acetate and human gonadotropins
article
OA: closed
CC0
⤵ 3 in-corpus citations
Abstract
Twenty-one patients with unexplained infertility underwent controlled ovarian hyperstimulation with buserelin acetate and human menopausal and chorionic gonadotropins, and follicular growth was monitored by ultrasonography and daily 17 beta-estradiol (E2) assays. Endometrial biopsy was performed when E2 levels were greater than or equal to 250 pg/mL per follicle and the follicular diameter was greater than or equal to 17 mm. As controls, we studied 20 preovulatory endometrial biopsies from patients with a male infertility factor. The biopsy material was examined at light, scanning, and transmission electron microscopes, and a morphometric analysis was performed. Preovulatory endometrial mucosa during controlled ovarian hyperstimulation showed accentuated proliferative aspects in both the glandular and stromal components and more frequent early secretory phenomena compared with the controls. The preovulatory progesterone (P) levels observed in our study seem to exclude the possibility that such early secretory aspects of the hyperstimulated endometrium are because of higher P concentrations in patients compared with controls.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (3)
- Mifepristone Is an Effective Oral Alternative for the Prevention of Premature Luteinizing Hormone Surges and/or Premature Luteinization in Women Undergoing Controlled Ovarian Hyperstimulation for<i>in Vitro</i>Fertilization 2005
- B-cell lymphoma 6 expression is not associated with live birth in a normal responder in vitro fertilization population 2021
- 8 Ovulation induction for luteal phase defects and luteal phase defects after ovulation induction 1993
References (13)
- W1984461414 via openalex
- W1990292091 via openalex
- W2022130851 via openalex
- W2119596519 via openalex
- W2155439584 via openalex
- W2160541120 via openalex
- W2404384565 via openalex
- W2409529349 via openalex
- W2410273940 via openalex
- W2411060742 via openalex
- W2418234429 via openalex
- W3124676488 via openalex
- W6682786284 via openalex
Cited by (3)
- B-cell lymphoma 6 expression is not associated with live birth in a normal responder in vitro fertilization population 2021
- Mifepristone Is an Effective Oral Alternative for the Prevention of Premature Luteinizing Hormone Surges and/or Premature Luteinization in Women Undergoing Controlled Ovarian Hyperstimulation for<i>in Vitro</i>Fertilization 2005
- 8 Ovulation induction for luteal phase defects and luteal phase defects after ovulation induction 1993
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0
· commercial use OK